Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001179110-15-012105
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-13 19:50:48
Reporting Period:
2015-08-11
Filing Date:
2015-08-13
Accepted Time:
2015-08-13 19:50:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1423824 Alder Biopharmaceuticals Inc ALDR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1026496 W Jon Bayless C/o Sevin Rosen Funds
13455 Noel Road, Suite 1670
Dallas TX 75240
No No No Yes
1033563 V John Jaggers C/o Sevin Rosen Funds
13355 Noel Road, Suite 1350
Dallas TX 75240
No No No Yes
1066600 R Alan Schuele C/o Sevin Rosen Funds
13455 Noel Road, Suite 1670
Dallas TX 75240
No No No Yes
1189256 L Stephen Domenik C/o Sevin Rosen Funds
13455 Noel Road, Suite 1670
Dallas TX 75240
No No No Yes
1189257 R Jackie Kimzey Sevin Rosen Funds
13355 Noel Road, Suite 1350
Dallas TX 75240
No No No Yes
1205949 T John Oxaal C/o Sevin Rosen Funds
13455 Noel Road, Suite 1670
Dallas TX 75240
No No No Yes
1205951 G Nicholas Sturiale C/o Sevin Rosen Funds
13455 Noel Road, Suite 1670
Dallas TX 75240
No No No Yes
1425210 J. David Mclean C/o Sevin Rosen Funds
13455 Noel Road, Suite 1670
Dallas TX 75240
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-08-11 115,358 $40.40 1,909,125 No 4 S Indirect See Footnote
Common Stock Disposition 2015-08-12 97,109 $40.03 1,812,016 No 4 S Indirect See Footnote
Common Stock Disposition 2015-08-12 1,795,752 $0.00 16,264 No 4 J Indirect See Footnote
Common Stock Acquisiton 2015-08-12 42 $0.00 16,306 No 4 J Indirect See Footnote
Common Stock Acquisiton 2015-08-12 4,115 $0.00 8,662 No 4 J Direct
Common Stock Acquisiton 2015-08-12 1,259 $0.00 2,651 No 4 J Direct
Common Stock Acquisiton 2015-08-12 3,316 $0.00 6,980 No 4 J Direct
Common Stock Acquisiton 2015-08-12 3,316 $0.00 6,980 No 4 J Direct
Common Stock Acquisiton 2015-08-15 2,517 $0.00 5,299 No 4 J Direct
Common Stock Acquisiton 2015-08-12 2,118 $0.00 4,458 No 4 J Direct
Common Stock Acquisiton 2015-08-12 4,115 $0.00 8,662 No 4 J Direct
Common Stock Acquisiton 2015-08-12 2,118 $0.00 4,458 No 4 J Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Direct
No 4 J Direct
No 4 J Direct
No 4 J Direct
No 4 J Direct
No 4 J Direct
No 4 J Direct
No 4 J Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.90 to $40.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities And Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  2. Total Common Shares of 1,909,125 represents 46 shares owned directly by SRB Associates IX L.P. ("SRBAIX"), 1,860,948 shares owned directly by Sevin Rosen Fund IX L.P. ("SRFIX"), 48,131 shares owned directly by Sevin Rosen IX Affiliates Fund L.P. ("SRFIX AFF"). John V. Jaggers ("Jaggers"), Jon W. Bayless ("Bayless") Stephen L. Domenik, ("Domenik"), Jackie R.Kimzey ("Kimzey") David J. McLean ("McLean"), John T. Oxaal ("Oxaal"), Alan R. Schuele ("Schuele") and Nicholas G. Sturiale ("Sturiale") are members of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and as members are deemed to have shared voting and dispositive power of the shares and disclaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.26 to $40.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities And Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  4. Total Common Shares of 1,812,016 represents 46 shares owned directly by SRBAIX, 1,765,877 shares owned directly by SRFIX and 46,093 shares owned directly by SRFIX AFF. Jaggers, Bayless, Domenik, Kimzey, McLean, Oxaal, Schuele and Sturiale are members of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and as members are deemed to have shared voting and dispositive power of the shares and disclaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares.
  5. Represents a pro-rata in-kind distribution, without additional consideration, of 1,750,000 shares of Common Stock of the Issuer by SRFIX and 45,752 shares of Common Stock of the Issuer by SRIXAFF.
  6. Total Common Shares of 16,264 represents 46 shares owned directly by SRBAIX, 15,877 shares owned directly by SRFIX and 341 shares owned directly by SRIX AFF. Jaggers, Bayless, Domenik, Kimzey, McLean, Oxaal, Schuele and Sturiale are members of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and as members are deemed to have shared voting and dispositive power of the shares and disclaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares.
  7. Represents the receipt of shares by SRBAIX of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  8. Total Common Shares of 16,306 represents 88 shares owned directly by SRBAIX, 15,877 shares owned directly by SRFIX and 341 shares owned directly by SRIX AFF. Jaggers, Bayless, Domenik, Kimzey, McLean, Oxaal, Schuele and Sturiale are members of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and as members are deemed to have shared voting and dispositive power of the shares and disclaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares.
  9. Represents the receipt of shares by Jaggers of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  10. Represents the receipt of shares by Bayless of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  11. Represents the receipt of shares by Domenik of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  12. Represents the receipt of shares by Kimzey of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  13. Represents the receipt of shares by McLean of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  14. Represents the receipt of shares by Oxaal of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  15. Represents the receipt of shares by Schuele of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  16. Represents the receipt of shares by Sturiale of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.